Market Cap 72.46M
Revenue (ttm) 66.28M
Net Income (ttm) -18.32M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -27.64%
Debt to Equity Ratio 0.22
Volume 6,600
Avg Vol 76,518
Day's Range N/A - N/A
Shares Out 45.57M
Stochastic %K 35%
Beta 1.20
Analysts Strong Buy
Price Target $7.00

Company Profile

InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, marketing, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally. The company offers dried cannabis inflorescences and cannabis extract mixed with oil. It also invests in the biomed sector. The company was incorporated in 1994 and is headquartered in Herzliya, Israel.

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 972 7 746 05012
Fax: 972 9 768 0244
Address:
85 Medinat ha-Yehudim Street, Herzliya, Israel
Hila11
Hila11 Oct. 9 at 1:28 PM
$CGEN $INCR 🔥🚀🔥🚀 https://www.biospace.com/press-releases/intercure-reports-first-half-2025-results-with-nis-130-million-in-revenue-and-positive-operating-cash-flow
0 · Reply
Hila11
Hila11 Oct. 9 at 1:27 PM
$BIAF $INCR 🔥🚀🔥 https://www.biospace.com/press-releases/intercure-reports-first-half-2025-results-with-nis-130-million-in-revenue-and-positive-operating-cash-flow
0 · Reply
Hila11
Hila11 Oct. 9 at 1:27 PM
$XTLB $INCR 🔥🚀🔥🚀 https://www.biospace.com/press-releases/intercure-reports-first-half-2025-results-with-nis-130-million-in-revenue-and-positive-operating-cash-flow
0 · Reply
Hila11
Hila11 Oct. 9 at 1:25 PM
$NVMI $INCR 🔥🚀🔥🚀 https://www.biospace.com/press-releases/intercure-reports-first-half-2025-results-with-nis-130-million-in-revenue-and-positive-operating-cash-flow
0 · Reply
Hila11
Hila11 Oct. 9 at 1:25 PM
$GILT $INCR 🔥🚀🔥🔥 https://www.biospace.com/press-releases/intercure-reports-first-half-2025-results-with-nis-130-million-in-revenue-and-positive-operating-cash-flow
0 · Reply
Hila11
Hila11 Oct. 9 at 1:24 PM
$ARBE $INCR 🔥🚀🔥 https://www.biospace.com/press-releases/intercure-reports-first-half-2025-results-with-nis-130-million-in-revenue-and-positive-operating-cash-flow
0 · Reply
Hila11
Hila11 Oct. 9 at 1:23 PM
$KDK $INCR 🔥🚀🔥 https://www.biospace.com/press-releases/intercure-reports-first-half-2025-results-with-nis-130-million-in-revenue-and-positive-operating-cash-flow
0 · Reply
Hila11
Hila11 Oct. 9 at 1:18 PM
$INCR 🚀🔥🔥 https://www.biospace.com/press-releases/intercure-reports-first-half-2025-results-with-nis-130-million-in-revenue-and-positive-operating-cash-flow
0 · Reply
Avi1970
Avi1970 Oct. 8 at 5:45 PM
$INCR The reports are good, the stock should rise, not fall.
0 · Reply
NVDAMillionaire
NVDAMillionaire Oct. 3 at 4:40 AM
$INCR Excellent article that nails exactly where INCR stands right now. So if you want to update your INCR knowledge or get acquainted with INCR, this is a must read. https://beyondspx.com/quote/INCR/analysis/intercure-s-global-cannabis-ambition-leveraging-gmp-and-tech-for-market-dominance-nasdaq-incr
0 · Reply
Latest News on INCR
InterCure: Bargain Israel Cannabis Play

Apr 22, 2024, 3:41 PM EDT - 1 year ago

InterCure: Bargain Israel Cannabis Play


InterCure Provides an Update Regarding Nir Oz Facility

Feb 13, 2024, 4:46 PM EST - 1 year ago

InterCure Provides an Update Regarding Nir Oz Facility


InterCure Wins Cannolam Arbitration Proceeding

Oct 31, 2023, 4:39 PM EDT - 2 years ago

InterCure Wins Cannolam Arbitration Proceeding


InterCure: Leader In Israel's Growing Medical Cannabis Market

Aug 2, 2023, 7:22 PM EDT - 2 years ago

InterCure: Leader In Israel's Growing Medical Cannabis Market


InterCure: How Bright Is The Company's Future In 2023

Apr 6, 2023, 10:24 AM EDT - 2 years ago

InterCure: How Bright Is The Company's Future In 2023


InterCure Ltd. (INCR) Q4 2022 Earnings Call Transcript

Apr 4, 2023, 6:56 PM EDT - 2 years ago

InterCure Ltd. (INCR) Q4 2022 Earnings Call Transcript


InterCure Reschedules 2022 Full Year Results Conference Call

Apr 3, 2023, 3:27 PM EDT - 2 years ago

InterCure Reschedules 2022 Full Year Results Conference Call


InterCure: Why The Company Is Grossly Undervalued By Wall Street

Jan 20, 2023, 12:22 PM EST - 2 years ago

InterCure: Why The Company Is Grossly Undervalued By Wall Street


Cannabis Is A Long-Term Play (Podcast Transcript)

Jan 9, 2023, 6:30 AM EST - 3 years ago

Cannabis Is A Long-Term Play (Podcast Transcript)


Cannabis REITs: Smoked Out

Dec 29, 2022, 11:15 AM EST - 3 years ago

Cannabis REITs: Smoked Out

ACB AFCG BYND CARA CGC CNBS CRON


Update regarding Better Transaction

Nov 23, 2022, 4:30 PM EST - 3 years ago

Update regarding Better Transaction


Buy InterCure To Ride The Coming Wave Of Global Cannabis Growth

Nov 8, 2022, 11:42 PM EST - 3 years ago

Buy InterCure To Ride The Coming Wave Of Global Cannabis Growth


InterCure: Highlighting A Profitable Israeli Cannabis Operator

Oct 25, 2022, 12:11 PM EDT - 3 years ago

InterCure: Highlighting A Profitable Israeli Cannabis Operator


InterCure: A Leader In Global Cannabis

Sep 6, 2022, 5:25 PM EDT - 3 years ago

InterCure: A Leader In Global Cannabis


Hila11
Hila11 Oct. 9 at 1:28 PM
$CGEN $INCR 🔥🚀🔥🚀 https://www.biospace.com/press-releases/intercure-reports-first-half-2025-results-with-nis-130-million-in-revenue-and-positive-operating-cash-flow
0 · Reply
Hila11
Hila11 Oct. 9 at 1:27 PM
$BIAF $INCR 🔥🚀🔥 https://www.biospace.com/press-releases/intercure-reports-first-half-2025-results-with-nis-130-million-in-revenue-and-positive-operating-cash-flow
0 · Reply
Hila11
Hila11 Oct. 9 at 1:27 PM
$XTLB $INCR 🔥🚀🔥🚀 https://www.biospace.com/press-releases/intercure-reports-first-half-2025-results-with-nis-130-million-in-revenue-and-positive-operating-cash-flow
0 · Reply
Hila11
Hila11 Oct. 9 at 1:25 PM
$NVMI $INCR 🔥🚀🔥🚀 https://www.biospace.com/press-releases/intercure-reports-first-half-2025-results-with-nis-130-million-in-revenue-and-positive-operating-cash-flow
0 · Reply
Hila11
Hila11 Oct. 9 at 1:25 PM
$GILT $INCR 🔥🚀🔥🔥 https://www.biospace.com/press-releases/intercure-reports-first-half-2025-results-with-nis-130-million-in-revenue-and-positive-operating-cash-flow
0 · Reply
Hila11
Hila11 Oct. 9 at 1:24 PM
$ARBE $INCR 🔥🚀🔥 https://www.biospace.com/press-releases/intercure-reports-first-half-2025-results-with-nis-130-million-in-revenue-and-positive-operating-cash-flow
0 · Reply
Hila11
Hila11 Oct. 9 at 1:23 PM
$KDK $INCR 🔥🚀🔥 https://www.biospace.com/press-releases/intercure-reports-first-half-2025-results-with-nis-130-million-in-revenue-and-positive-operating-cash-flow
0 · Reply
Hila11
Hila11 Oct. 9 at 1:18 PM
$INCR 🚀🔥🔥 https://www.biospace.com/press-releases/intercure-reports-first-half-2025-results-with-nis-130-million-in-revenue-and-positive-operating-cash-flow
0 · Reply
Avi1970
Avi1970 Oct. 8 at 5:45 PM
$INCR The reports are good, the stock should rise, not fall.
0 · Reply
NVDAMillionaire
NVDAMillionaire Oct. 3 at 4:40 AM
$INCR Excellent article that nails exactly where INCR stands right now. So if you want to update your INCR knowledge or get acquainted with INCR, this is a must read. https://beyondspx.com/quote/INCR/analysis/intercure-s-global-cannabis-ambition-leveraging-gmp-and-tech-for-market-dominance-nasdaq-incr
0 · Reply
Avi1970
Avi1970 Sep. 30 at 5:16 PM
$INCR Who are we waiting for?
0 · Reply
WallStWireAds
WallStWireAds Sep. 30 at 12:53 PM
0 · Reply
JesusWhale
JesusWhale Sep. 29 at 9:36 PM
$INCR I presume all of the sell pressure today was from the recent acquisition of ISHI. A good day to unload shares, as this stock had unusually high daily volume thanks to Mr. Trump pumping up the sector. "The company said that it would acquire ISHI in two phases. The company would initially acquire 50% of equity for about 2.47 million InterCure ordinary shares. " I think the acquisition is brilliant. The timing could prove particularly advantageous for InterCure, securing exclusive partnerships with premium American cannabis brands including The Flowery, a leading vertically integrated medical cannabis company with operations in Florida and New York. Immediate access to the American market with its GMP (highest medical grade) cannabis. Let's not forget who sits on Intercures board, Former prime minister Ehud Barak. We all know Trump gets along with the Israeli's, so it's possible Intcercure has insider info that the cannabis will be rescheduled!
0 · Reply
tushal1980
tushal1980 Sep. 29 at 4:28 PM
$INCR what the fuck happened here everything is up except this
1 · Reply
WallStWireAds
WallStWireAds Sep. 29 at 3:39 PM
$TLRY $AKAN $KAVL $INCR https://alphacatalyst.beehiiv.com/p/intercure-stock-eyes-breakout-as-new-attention-as-trump-signals-cannabis-rescheduling-expanding-flow
0 · Reply
WallStWireAds
WallStWireAds Sep. 29 at 3:34 PM
$INCR https://alphacatalyst.beehiiv.com/p/intercure-stock-eyes-breakout-as-new-attention-as-trump-signals-cannabis-rescheduling-expanding-flow
0 · Reply
Avi1970
Avi1970 Sep. 29 at 12:34 PM
$INCR incr is perhaps the cheapest company in cannabis stocks
0 · Reply
WallStWireAds
WallStWireAds Sep. 29 at 10:09 AM
$INCR https://www.reuters.com/business/healthcare-pharmaceuticals/cannabis-stocks-surge-after-trump-endorses-cannabidiol-senior-healthcare-2025-09-29/
0 · Reply
WallStWireAds
WallStWireAds Sep. 25 at 7:23 PM
$INCR https://venture-block.com/israeli-cannabis-leader-intercure-snatches-up-premium-tech-company-in-perfect-pre-rescheduling-play/
0 · Reply
WallStWireAds
WallStWireAds Sep. 19 at 8:17 PM
$INCR https://thefinanceherald.com/trumps-cannabis-rescheduling-push-could-create-massive-opportunity-and-this-company-is-perfectly-positioned/
0 · Reply
StocktwitsNews
StocktwitsNews Sep. 19 at 1:11 PM
InterCure To Buy ISHI In All-Stock Transaction – Find Out More $INCR https://stocktwits.com/news/equity/markets/intercure-to-buy-ishi-in-all-stock-transaction/chD3PW9R3TT
0 · Reply
BigSqueezeComing
BigSqueezeComing Sep. 19 at 12:54 PM
$INCR InterCure Announces Strategic Acquisition of ISHI, Unlocking Access to Premium U.S. Cannabis Technology and Brands By InterCure Ltd. | September 19, 2025, 8:48 AM
0 · Reply